David N. Brindley

Biochemistry University of Alberta, Edmonton, Alberta, Canada 
"David Brindley"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Benesch MG, Wu R, Tang X, et al. (2023) Autotaxin production in the human breast cancer tumor microenvironment mitigates tumor progression in early breast cancers. American Journal of Cancer Research. 13: 2790-2813
Benesch MGK, Wu R, Tang X, et al. (2023) Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression. International Journal of Molecular Sciences. 24
Benesch MGK, Wu R, Tang X, et al. (2023) Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion. Cancers. 15
Venkatraman G, Tang X, Du G, et al. (2021) Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance. Cell Biochemistry and Biophysics
Brindley DN, Tang X, Meng G, et al. (2020) Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer. International Journal of Molecular Sciences. 21
Hemmings DG, Brindley DN. (2020) Signalling by lysophosphatidate and its health implications. Essays in Biochemistry
Meng G, Wuest M, Tang X, et al. (2020) Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis. Cancers. 12
Tang X, Benesch MGK, Brindley DN. (2020) Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 158716
Benesch MGK, Tang X, Brindley DN. (2020) Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae. Cancers. 12
Elian FA, Are U, Nuin P, et al. (2020) FOXQ1 is differentially expressed across breast cancer subtypes and potentially can serve as a prognostic marker The Faseb Journal. 34: 1-1
See more...